Back to VANGUARD GROUP INC VANGUARD GROUP INC

BCLIBCLI
4 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in BrainStorm Cell Therapeutics In

VANGUARD GROUP INC previously held 0 shares of BCLI (BrainStorm Cell Therapeutics In), worth $0 as of 2025-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$178,061

Total Shares Change

-78,441

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$0.70
0
2025-Q2
Unchanged
27,724
0.0%
$31,0510.0%$1.06
0
2025-Q1
Decreased
27,724
-64.7%
$34,9320.0%$1.19
0
2024-Q4
New
78,441
-
$178,0610.0%$2.37
35

Other major holders of BCLI: GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., HRT FINANCIAL LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used